Clinical Trial Simulations - AAPS Advances in the Pharmaceutical Sciences Series
Latest Publications

TOTAL DOCUMENTS

(FIVE YEARS 0)

H-INDEX

(FIVE YEARS 0)

Published By Springer New York

9781441974143, 9781441974150

Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

Balancing Efficacy and Safety in the Clinical Development of an Atypical Antipsychotic, Paliperidone Extended-Release

Clinical Trial Simulations - AAPS Advances in the Pharmaceutical Sciences Series ◽

10.1007/978-1-4419-7415-0_16 ◽

2010 ◽

pp. 341-357

Author(s):

Filip De Ridder ◽

An Vermeulen

Keyword(s):

Atypical Antipsychotic ◽

Extended Release ◽

Clinical Development ◽

Efficacy And Safety ◽

Paliperidone Extended Release

Leveraging Pharmacometrics in Early Phase Anti-inflamatory Drug Development

Clinical Trial Simulations - AAPS Advances in the Pharmaceutical Sciences Series ◽

10.1007/978-1-4419-7415-0_8 ◽

2010 ◽

pp. 149-172

Author(s):

Ene I. Ette ◽

Christopher J. Godfrey

Keyword(s):

Drug Development ◽

Early Phase

Decision-Making in Drug Development: Application of a Model Based Framework for Assessing Trial Performance

Clinical Trial Simulations - AAPS Advances in the Pharmaceutical Sciences Series ◽

10.1007/978-1-4419-7415-0_4 ◽

2010 ◽

pp. 61-83 ◽

Cited By ~ 2

Author(s):

Mike K. Smith ◽

Jonathan L. French ◽

Kenneth G. Kowalski ◽

Matthew M. Hutmacher ◽

Wayne Ewy

Keyword(s):

Decision Making ◽

Drug Development ◽

Model Based ◽

Development Application ◽

Trial Performance

Contribution of Modeling and Simulation Studies in the Regulatory Review: A European Regulatory Perspective

Clinical Trial Simulations - AAPS Advances in the Pharmaceutical Sciences Series ◽

10.1007/978-1-4419-7415-0_2 ◽

2010 ◽

pp. 15-36 ◽

Cited By ~ 3

Author(s):

Siv Jönsson ◽

Anja Henningsson ◽

Monica Edholm ◽

Tomas Salmonson

Keyword(s):

Modeling And Simulation ◽

Simulation Studies ◽

Regulatory Review ◽

Regulatory Perspective ◽

European Regulatory

Model Based Development of an Agent for the Treatment of Generalized Anxiety Disorder

Clinical Trial Simulations - AAPS Advances in the Pharmaceutical Sciences Series ◽

10.1007/978-1-4419-7415-0_15 ◽

2010 ◽

pp. 325-340

Author(s):

Peter A. Lockwood ◽

Jaap W. Mandema

Keyword(s):

Anxiety Disorder ◽

Generalized Anxiety Disorder ◽

Generalized Anxiety ◽

Model Based

Recent Developments in Physiologically Based Pharmacokinetic Modeling

Clinical Trial Simulations - AAPS Advances in the Pharmaceutical Sciences Series ◽

10.1007/978-1-4419-7415-0_21 ◽

2010 ◽

pp. 483-499 ◽

Cited By ~ 1

Author(s):

Vikash Sinha ◽

Holly H. C. Kimko

Keyword(s):

Pharmacokinetic Modeling ◽

Physiologically Based Pharmacokinetic Modeling ◽

Physiologically Based Pharmacokinetic ◽

Physiologically Based ◽

Recent Developments

A Model-Based PK/PD Antimicrobial Chemotherapy Drug Development Platform to Simultaneously Combat Infectious Diseases and Drug Resistance

Clinical Trial Simulations - AAPS Advances in the Pharmaceutical Sciences Series ◽

10.1007/978-1-4419-7415-0_12 ◽

2010 ◽

pp. 251-279 ◽

Cited By ~ 3

Author(s):

N. L’ntshotsholé “Shasha” Jumbe ◽

George L. Drusano

Keyword(s):

Drug Resistance ◽

Infectious Diseases ◽

Drug Development ◽

Antimicrobial Chemotherapy ◽

Chemotherapy Drug ◽

Development Platform ◽

Model Based

Application of Modeling and Simulation in the Development of Protein Drugs

Clinical Trial Simulations - AAPS Advances in the Pharmaceutical Sciences Series ◽

10.1007/978-1-4419-7415-0_17 ◽

2010 ◽

pp. 361-396 ◽

Cited By ~ 3

Author(s):

Lorin K. Roskos ◽

Song Ren ◽

Gabriel Robbie

Keyword(s):

Modeling And Simulation ◽

Protein Drugs

Keys of Collaboration to Enhance Efficiency and Impact of Modeling and Simulation

Clinical Trial Simulations - AAPS Advances in the Pharmaceutical Sciences Series ◽

10.1007/978-1-4419-7415-0_7 ◽

2010 ◽

pp. 131-148

Author(s):

Anthe S. Zandvliet ◽

Rik de Greef ◽

Anton F. J. de Haan ◽

Pieta C. IJzerman-Boon ◽

Maya Z. Marintcheva-Petrova ◽

...

Keyword(s):

Modeling And Simulation ◽

Enhance Efficiency

Modeling and Simulation in the Development of Cardiovascular Agents

Clinical Trial Simulations - AAPS Advances in the Pharmaceutical Sciences Series ◽

10.1007/978-1-4419-7415-0_10 ◽

2010 ◽

pp. 199-226

Author(s):

Diane R. Mould ◽

Bill Frame ◽

Timothy Taylor

Keyword(s):

Modeling And Simulation ◽

Cardiovascular Agents

Clinical Trial Simulations - AAPS Advances in the Pharmaceutical Sciences SeriesLatest Publications

TOTAL DOCUMENTS

H-INDEX

Published By Springer New York

Balancing Efficacy and Safety in the Clinical Development of an Atypical Antipsychotic, Paliperidone Extended-Release

Leveraging Pharmacometrics in Early Phase Anti-inflamatory Drug Development

Decision-Making in Drug Development: Application of a Model Based Framework for Assessing Trial Performance

Contribution of Modeling and Simulation Studies in the Regulatory Review: A European Regulatory Perspective

Model Based Development of an Agent for the Treatment of Generalized Anxiety Disorder

Recent Developments in Physiologically Based Pharmacokinetic Modeling

A Model-Based PK/PD Antimicrobial Chemotherapy Drug Development Platform to Simultaneously Combat Infectious Diseases and Drug Resistance

Application of Modeling and Simulation in the Development of Protein Drugs

Keys of Collaboration to Enhance Efficiency and Impact of Modeling and Simulation

Modeling and Simulation in the Development of Cardiovascular Agents

Clinical Trial Simulations - AAPS Advances in the Pharmaceutical Sciences Series
Latest Publications